BeyondSpring Files 2023 Annual Report on Form 20-F
29.04.2024 - FLORHAM PARK, N.J., April 29, 2024 (GLOBE NEWSWIRE) - BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it ...
Source: wallstreet-online.de